# Efficacy of Quetiapine XR Versus Placebo as Concomitant Treatment to Mood Stabilizers in the Control of Subsyndromal Symptoms of Bipolar Disorder

> **NCT01197846** · PHASE3 · COMPLETED · sponsor: **Centro de Investigación Biomédica en Red de Salud Mental** · enrollment: 28 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Quetiapine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01197846
- **Lead sponsor:** Centro de Investigación Biomédica en Red de Salud Mental
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2012-02
- **Final completion:** 2012-07
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2012-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01197846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01197846, "Efficacy of Quetiapine XR Versus Placebo as Concomitant Treatment to Mood Stabilizers in the Control of Subsyndromal Symptoms of Bipolar Disorder". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01197846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*